Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Parenthetical)

v3.26.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Allowance for credit losses $ 75 $ 79
Accumulated depreciation 977 974
Current portion of debt, fair value $ 36 $ 52
Series A common stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 4,000,000,000 4,000,000,000
Common stock, shares issued (in shares) 7,911,869 7,903,233
Common stock, shares outstanding (in shares) 7,911,869 7,903,233
Series B common stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 150,000,000 150,000,000
Common stock, shares issued (in shares)   182,233
Common stock, shares outstanding (in shares) 182,233  
Series C common stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 4,000,000,000 4,000,000,000
Common stock, shares issued (in shares) 0 0